Bausch Health Cos Price to Free Cash Flow Ratio 2012-2026 | BHC
Historical price to free cash flow ratio values for Bausch Health Cos (BHC) since 2012.
| Bausch Health Cos Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2026-06-18 | 4.77 | 0.00 | |
| 2026-03-31 | 5.40 | $-0.26 | 0.00 |
| 2025-12-31 | 6.95 | 0 | 0.00 |
| 2025-09-30 | 6.45 | $2.95 | 2.19 |
| 2025-06-30 | 6.66 | $3.03 | 2.20 |
| 2025-03-31 | 6.47 | $3.33 | 1.94 |
| 2024-12-31 | 8.06 | $3.42 | 2.35 |
| 2024-09-30 | 8.16 | $2.88 | 2.83 |
| 2024-06-30 | 6.97 | $2.63 | 2.65 |
| 2024-03-31 | 10.61 | $2.30 | 4.62 |
| 2023-12-31 | 8.02 | $2.24 | 3.58 |
| 2023-09-30 | 8.22 | $2.55 | 3.22 |
| 2023-06-30 | 8.00 | $-1.73 | 0.00 |
| 2023-03-31 | 8.10 | $-2.02 | 0.00 |
| 2022-12-31 | 6.28 | $-2.61 | 0.00 |
| 2022-09-30 | 6.89 | $-3.81 | 0.00 |
| 2022-06-30 | 8.36 | $2.94 | 2.85 |
| 2022-03-31 | 22.85 | $3.72 | 6.15 |
| 2021-12-31 | 27.61 | $5.09 | 5.43 |
| 2021-09-30 | 27.85 | $6.12 | 4.55 |
| 2021-06-30 | 29.32 | $3.43 | 8.56 |
| 2021-03-31 | 31.74 | $2.81 | 11.29 |
| 2020-12-31 | 20.80 | $2.34 | 8.90 |
| 2020-09-30 | 15.54 | $1.83 | 8.48 |
| 2020-06-30 | 18.29 | $2.66 | 6.87 |
| 2020-03-31 | 15.50 | $3.11 | 4.99 |
| 2019-12-31 | 29.92 | $3.62 | 8.26 |
| 2019-09-30 | 21.85 | $3.91 | 5.58 |
| 2019-06-30 | 25.22 | $4.16 | 6.06 |
| 2019-03-31 | 24.70 | $3.90 | 6.33 |
| 2018-12-31 | 18.47 | $3.92 | 4.71 |
| 2018-09-30 | 25.67 | $5.23 | 4.90 |
| 2018-06-30 | 23.24 | $13.68 | 1.70 |
| 2018-03-31 | 15.92 | $13.78 | 1.15 |
| 2017-12-31 | 20.78 | $15.27 | 1.36 |
| 2017-09-30 | 14.33 | $14.76 | 0.97 |
| 2017-06-30 | 17.30 | $6.32 | 2.74 |
| 2017-03-31 | 11.03 | $7.09 | 1.56 |
| 2016-12-31 | 14.52 | $5.91 | 2.46 |
| 2016-09-30 | 24.55 | $6.03 | 4.07 |
| 2016-06-30 | 20.14 | $6.51 | 3.09 |
| 2016-03-31 | 26.30 | $6.13 | 4.29 |
| 2015-12-31 | 101.65 | $5.94 | 17.12 |
| 2015-09-30 | 178.38 | $6.50 | 27.43 |
| 2015-06-30 | 222.15 | $10.56 | 21.04 |
| 2015-03-31 | 198.62 | $10.25 | 19.38 |
| 2014-12-31 | 143.11 | $10.28 | 13.92 |
| 2014-09-30 | 131.20 | $8.85 | 14.82 |
| 2014-06-30 | 126.12 | $3.25 | 38.82 |
| 2014-03-31 | 131.83 | $3.47 | 37.98 |
| 2013-12-31 | 117.40 | $3.02 | 38.94 |
| 2013-09-30 | 104.33 | $2.44 | 42.80 |
| 2013-06-30 | 86.08 | $2.36 | 36.43 |
| 2013-03-31 | 75.02 | $2.19 | 34.21 |
| 2012-12-31 | 59.77 | $2.10 | 28.48 |
| 2012-09-30 | 55.27 | $2.39 | 23.08 |
| 2012-06-30 | 44.79 | $2.57 | 17.41 |
| 2012-03-31 | 53.69 | $2.42 | 22.16 |
| 2011-12-31 | 46.69 | $1.89 | 24.64 |
| 2011-09-30 | 37.12 | $1.04 | 35.62 |
| 2011-06-30 | 51.96 | $1.21 | 42.94 |
| 2011-03-31 | 49.81 | $1.22 | 40.95 |
| 2010-12-31 | 28.29 | $1.34 | 21.19 |
| 2010-09-30 | 24.08 | $2.56 | 9.43 |
| 2010-06-30 | 18.42 | $2.44 | 7.54 |
| 2010-03-31 | 15.96 | $2.43 | 6.57 |
| 2009-12-31 | 13.20 | $2.41 | 5.48 |
| 2009-09-30 | 14.50 | $2.19 | 6.62 |
| 2009-06-30 | 12.55 | $1.20 | 10.48 |
| 2009-03-31 | 10.14 | $0.93 | 10.94 |
| 2008-12-31 | 8.45 | $1.15 | 7.35 |
| 2008-09-30 | 8.38 | $0.90 | 9.30 |
| 2008-06-30 | 7.98 | $2.78 | 2.86 |
| 2008-03-31 | 8.55 | $1.70 | 5.02 |
| 2007-12-31 | 10.46 | $1.90 | 5.51 |
| 2007-09-30 | 13.21 | $3.99 | 3.31 |
| 2007-06-30 | 18.89 | $1.90 | 9.95 |
| 2007-03-31 | 16.01 | $3.21 | 4.99 |
| 2006-12-31 | 14.88 | $2.98 | 5.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $2.086B | $10.266B |
| Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |